Advanced pediatric psychopharmacology.
Vito
Jose
J
Division of Child and Adolescent Psychiatry, State University of New York, Brooklyn, New York, USA.
Jummani
Rahil
R
Coffey
Barbara
B
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068180:Aripiprazole; D001714:Bipolar Disorder / Q000175:diagnosis* / Q000188:drug therapy* / Q000523:psychology; D002186:Cannabinoids / Q000633:toxicity*; D003131:Combined Modality Therapy; D015897:Comorbidity; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D002189:Marijuana Abuse / Q000150:complications* / Q000175:diagnosis* / Q000523:psychology; D008609:Mental Status Schedule; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology*; D010359:Patient Readmission; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D011379:Prognosis; D011605:Psychoses, Substance-Induced / Q000175:diagnosis* / Q000188:drug therapy* / Q000523:psychology; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence; D012931:Social Environment; D013844:Thiazoles / Q000009:adverse effects / Q000627:therapeutic use; D016312:Treatment Refusal
D014150:Antipsychotic Agents; D002186:Cannabinoids; D010879:Piperazines; D015363:Quinolones; D013844:Thiazoles; C092292:ziprasidone; D000068180:Aripiprazole